Sanofi TB Drug In India Sanofi is likely to be granted marketing
authorization for its new anti-tuberculosis medicine rifapentine India
soon. The Subject Experts Committee (SEC) for Antimicrobials &
Antivirals has reportedly recommended CDSCO to grant conditional
approval to import and market rifapentine. The Central Drugs Standard
Control Organization is the primary drug regulator in […]
The post Sanofi To Get Grants For Marketing It's TB Drug In India
appeared first on Rasayanika .
https://www.rasayanika.com/2019/11/06/sanofi-to-get-grants-for-marketing-its-tb-drug-in-india/
Uncategorized
No comments:
Post a Comment